Chris Crowell, Ph.D.
About Chris Crowell, Ph.D.
Chris Crowell, Ph.D., serves as the Vice President of Manufacturing Operations at Kite Pharma, where he focuses on developing future leaders in the healthcare industry. He has extensive experience in operations and quality development, having held various leadership roles at Amgen and Kite Pharma over a career spanning more than two decades.
Current Role at Kite Pharma
Chris Crowell, Ph.D., currently serves as Vice President of Manufacturing Operations at Kite Pharma. He has held this position since 2023 and is based in Hoofddorp, North Holland, Netherlands. In this role, he focuses on overseeing manufacturing operations, ensuring efficiency and quality in the production of innovative therapies.
Previous Experience at Amgen
Before joining Kite Pharma, Chris Crowell worked at Amgen for several years in various leadership roles. He served as Executive Director, Plant Manager Drug Substance from 2020 to 2021 and as Executive Director, Global Operations from 2015 to 2020, both in Thousand Oaks, California. His tenure at Amgen spanned 24 years, during which he contributed as a Member of Quality and Process Development.
Educational Background
Chris Crowell earned his Bachelor of Science degree in Biological Sciences from the University of California, Santa Barbara, where he studied from 1992 to 1996. He later pursued a Ph.D. in Pharmaceutical Sciences at the University of Colorado Anschutz Medical Campus, completing his studies from 2001 to 2006.
Leadership Development Focus
Chris Crowell has a strong focus on developing future leaders within the healthcare industry. His commitment to leadership development is evident in his various roles, where he has aimed to foster talent and enhance operational capabilities in the organizations he has worked for.
Passion for Innovative Medicines
Chris Crowell is passionate about bringing innovative medicines through the commercialization process. He aims to positively impact patients' lives by ensuring that new therapies are effectively developed and made available to those in need.